| ILMN | 1.83% | 94.77 | -1.43% | 173,095 | |
| NBIX | 1.77% | 131.83 | -0.14% | 122,063 | |
| 068270 | 1.77% | 181,200 | +0.50% | 127,530 | |
| JNJ | 1.75% | 164.41 | +0.43% | 97,374 | |
| 6160 | 1.72% | 175.60 | -3.89% | 750,500 | |
| UCB | 1.72% | 173.30 | -0.89% | 80,506 | |
| BSX | 1.72% | 103.81 | +0.16% | 153,308 | |
| AMGN | 1.69% | 295.89 | +0.38% | 51,911 | |
| MDT | 1.68% | 89.70 | +0.10% | 172,345 | |
| MRK | 1.68% | 79.31 | -0.81% | 187,253 |
iShares IV Public Limited Company - iShares Healthcare Innovation UCITS ETF is an exchange traded fund launched by BlackRock Asset Management Ireland Limited. The fund is managed by BlackRock Advisors (UK) Limited. It invests in public equity markets across the globe. The fund invests in stocks of companies operating in the healthcare innovation sector. It invests in stocks of small-cap, mid-cap and large-cap companies. The fund seeks to track the performance of the iSTOXX FactSet Breakthrough Healthcare Index, by employing representative sampling methodology. iShares IV Public Limited Company - iShares Healthcare Innovation UCITS ETF was formed on September 8, 2016 and is domiciled in Ireland.